Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--Occidental Petroleum Maintains Quarterly Dividend at $0.22 a Share, Payable July 15 to Shareholders of Record June 10
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--Occidental Petroleum Maintains Quarterly Dividend at $0.22 a Share, Payable July 15 to Shareholders of Record June 10
May 1, 2024 10:00 AM
12:36 PM EDT, 05/01/2024 (MT Newswires) --
Price: 64.09, Change: -2.06, Percent Change: -3.11
Previous page:
Update: ShaMaran Closes Transaction to Increase Its Working Interest in the Atrush Block in Iraq's Kurdistan Region
Next page:
Update: KITS Eyecare Up 3.4% as It Swings to Q2 Profit as Revenue Hits a Record High
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Update: ShaMaran Closes Transaction to Increase Its Working Interest in the Atrush Block in Iraq's Kurdistan Region
Aug 7, 2024
11:49 AM EDT, 08/07/2024 (MT Newswires) -- ShaMaran Petroleum ( SHASF ) on Wednesday said it closed the acquisition of TAQA Atrush and the subsequent sale of an indirect interest in Atrush to HKN Energy IV. The two-step transaction announced in January increased ShaMaran's 28% indirect stake in the Atrush oil block in Iraq's Kurdistan region to a 50% working...
Update: KITS Eyecare Up 3.4% as It Swings to Q2 Profit as Revenue Hits a Record High
Aug 7, 2024
11:45 AM EDT, 08/07/2024 (MT Newswires) -- KITS Eyecare ( KTYCF ) on Wednesday said it swung to a profit in the second-quarter as revenue jumped 26% to a record. The on-line eyeglasses company said its second-quarter came in at $187,000, or $0.01 per share, swinging from a loss of $1.2 million, or $0.04, in the year-prior period. Revenue rose...
Takeda Wins European Commission's Approval for Adzynma to Treat Blood Clotting Disorder
Aug 7, 2024
11:45 AM EDT, 08/07/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) said Wednesday it received approval from the European Commission for Adzynma for the treatment of congenital thrombotic thrombocytopenic purpura, a rare blood clotting disorder caused by a deficiency in the ADAMTS13 enzyme. Takeda said the EC approval does not have any impact on its consolidated forecast for the...
Vaccine Maker Emergent BioSolutions Expects Deeper Losses In 2024, Stock Sinks
Aug 7, 2024
On Tuesday, Emergent BioSolutions Inc. ( EBS ) reported second-quarter 2024 sales of $254.7 million, down 25% year over year, beating the consensus of $190 million. The company reported an adjusted EPS loss of $(2.32), more than double the $(1.05) reported a year ago, missing the consensus of $(0.94). Revenues from Narcan (naloxone HCl) Nasal Spray decreased 10% to $120 million, primarily...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2025 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP